May 8, 2018
Sernova (TSX-V:SVA) announces Dr. Piotr Witkowski, M.D., Ph.D., a leading expert in type 1 diabetes (T1D) and islet transplantation, as...
July 24, 2017
Sernova announced an update for its personalized regenerative medicine therapy for the treatment of Hemophilia A patients.
April 24, 2017
A look at the top life science stocks on the TSXV Top 50 Companies.
November 2, 2016
Sernova Corp. today announces a regulatory collaboration with CTI Clinical Trial and Consulting Services on Sernova's Cell Pouch System.
June 27, 2016
LONDON, ONTARIO–(Marketwired – June 27, 2016) – Sernova Corp. (“Sernova” or the “Company”) (TSX VENTURE:SVA)(OTCQB:SEOVF)(FRANKFURT:PSH) is pleased to announce that...
January 26, 2016
Sernova Corp. (TSXV:SVA, FWB:PSH, OTCQB:SEOVF) entered into a service agreement with the Centre for Commercialization of Regenerative Medicine (CCRM) to...
September 11, 2015
Sernova (TSX-V:SVA) (FSE:PSH) has announced a licence agreement with the University Health Nework of Toronto, securing worldwide commercial rights to...